Chiocca E.A., Choi B.B., Cai W.,
DeLuca N.A., Schaffer P.A., DiFiglia M., Breakefield X.O., Martuza
R.L.: Transfer and expression of the lac Z gene in rat brain neurons
mediated by herpes simplex virus mutants. New Biol. 2: 739-746,
1990.
Yu J., Wei M.X., Chiocca E.A., Martuza
R.L., Tepper R.L.: Treatment of human glioma by engineered interleukin-4
secreting cells. Cancer Res 53, 3125-3128, 1993.
Chiocca E.A., Tamiya T., Boviatsis,
E.J., Filipek, P.A., Breakefield X.O., Kennedy D.N.: Gene therapy
for gliomas using virus vectors. Neuroimmunol. Res. 6 (Japan),
23-32, 1993.
Boviatsis E.J., Chase M., Wei M.X.,
Tamiya T., Hurford R.K. Jr., Kowall N.W., Tepper R.I., Breakefield
X.O., Chiocca E.A.: Gene transfer into experimental brain tumors
mediated by adenovirus, herpes simplex virus (HSV), and retrovirus
vectors. Human Gene Therapy 5, 183-191, 1994.
Pakzaban P. and Chiocca E.A : Nerve
growth factor protects against herpes simplex virus type 1 neurotoxicity
in the rat striatum. NeuroReport 5, 993-996, 1994.
Scharf J.M., Boviatsis E.J., Fleet
C., Breakefield X.O., and Chiocca E.A.: Genetically modified rat
9L gliosarcoma cells facilitate detection of infiltrating tumor
cells in a rat model of brain neoplasms. Transgenics 1, 219-224,
1994.
M.X. Wei, T. Tamiya, M. Chase, E.J.
Boviatsis, T.K.H. Chang, F. H. Hochberg, N.W. Kowall, D.J. Waxman,
X.O. Breakefield, E.A. Chiocca. Experimental tumor therapy in
mice with the cyclophosphamide-activating cytochrome P450 2B1
gene. Human Gene Therapy 5, 969-978, 1994.
Boviatsis E.J., Scharf J.M., Chase
M., Harrington K., Breakefield X.O., Chiocca E.A.: Antitumor activity
and reporter gene transfer into rat brain neoplasms inculated
with herpes simplex virus vectors defective in thymidine kinase
or ribonucleotide reductase. Gene Therapy 1, 323-331, 1994.
E. A. Chiocca, E. J. Boviatsis, R.
M. Westmark, M. P. Short, E. P. Richardson, N.T. Zervas. Deep
sylvian fissure meningioma without dural attachment in an adult.
Case report. Neurosurgery , 944-946, 1994.
Boviatsis, E.J., Park, J.S., Sena-Esteves,
M., Kramm, C., Chase, M., Efird, J., Wei, M.X., Breakefield, X.O.,
Chiocca, E.A.: Long- term survival of rats harboring brain tumors
treated with ganciclovir and a herpes simplex virus vector that
maintains an intact thymidine kinase gene. Cancer Research 54,
5745-5751, 1994.
Tamiya, T., Wei, M.X., Breakefield,
X.O., Chiocca, E.A., Ohmoto, T.: Gene therapy for brain tumors:
gene therapy for brain tumors using prodrug-sensitivity genes.
Neurological Surgery (Japan) 22, 1099-1110, 1994.
Wei, M.X., Tamiya, T., Hurford, R.K.,
Boviatsis, E.J., Tepper, R.I., Chiocca, E.A.: Enhancement of interleukin
4-mediated tumor regression in athymic mice by in situ retroviral
gene transfer. Human Gene Therapy 6, 439-445, 1995.
Tamiya, T., Wei. M.X., Ono, Y., Chase,
M., Breakefield, X.O., Chiocca, E.A.: Transgene inheritance and
retroviral infection contribute to the efficiency of gene expression
in solid tumors inoculated with retroviral vector producer cells.
Gene Therapy 2, 531-538, 1995.
Wei M.X., Tamiya, T., Rhee, R.J.,
Breakefield X.O., and Chiocca, E.A.: Diffusible cytotoxic metabolites
contribute to the in vitro bystander effect associated with cyclophosphamide/
cytochrome P450 2B1 gene therapy. Clinical Cancer Research 1,
1171-1177, 1995.
Speliotes E.K., Wei M.X., Weise J.,
Fleet C., Do T., Shanti B., Chiocca E.A., Finklestein S.P., and
Breakefield X.O.: Signal Peptide-basic fibroblast growth factor
(sp-bFGF) transforms fibroblast line in vitro but restricts fibroma
growth in brain. Transgenics 1, 573-584 , 1995.
Rainov, N.G., Zimmer, C., Chase,
M., Kramm, C., Chiocca, E.A., Weissleder, R., Breakefield, X.O.:
Selective intra-arterial delivery of viral and microcrystalline
particles to experimental brain tumors. Human Gene Therapy 6:
1543-1552, 1995.
Muldoon, L.L., Nilaver, G., Kroll,
R.A., Pagel, M.A., Breakefield, X.O., Chiocca, E.A., Davidson,
B.L., Weissleder, R., Neuwelt, E.A.: Use of monocrystalline iron
oxide nanocompound to monitor the distribution of adenovirus and
herpesvirus in normal rat brain: comparison of delivery by direct
inoculation and osmotic blood-brain barrier disruption. Am. J.
Pathol. 147: 1840- 1851, 1995.
Kramm, C.M., Sena-Esteves, M., Barnett,
F.H., Rainov, N.G., Schuback, D.E., Yu, J.S., Pechan, P.A., Paulus,
W., Chiocca, E.A., Breakefield, X.O.: Gene Therapy for Brain Tumors
(Review). Brain Pathology 5: 345-381, 1995
Kramm, C.M., Rainov, N.G., Sena-Esteves,
M., Chase, M., Pechan, P., Chiocca, E.A., Breakefield, X.O.: Herpes
vector-mediated delivery of thymidine kinase gene to disseminated
CNS tumors. Human Gene Therapy 7: 291-300, 1996.
Tamiya, T., Ono, Y., Wei, M.X. Mroz,
P., Moolten, F.L., and Chiocca, E.A.: The Escherichia Coli gpt
gene sensitizes rat glioma cells to killing by 6-thioxanthine
or 6-thioguanine. Cancer Gene Therapy 3: 155-162, 1996.
Rainov, N.G., Kramm, C.K., Aboody-Gutterman,
K., Chase, M.,Ueki, K., , Louis, D.N., Harsh IV, G.R., Chiocca,
E.A., Breakefield, X.O.: Retrovirus-mediated gene therapy of experimental
brain neoplasms using the HSV-TK/ganciclovir paradigm. Cancer
Gene Therapy 3: 99-106, 1996.
Pechan, P., , Chase, M., DeLuca,
N.A., Thompson, R., Chiocca, E.A. and Breakefield, X.O.: A novel
herpes simplex virus "piggyback" packaging system for
amplicon vectors. Human Gene therapy: in press, 1996.
Kramm, C.K., Rainov, N.G., Sena-Esteves,
M., Barnett, F.H., Chase, M., Chiocca, E.A., Breakefield, X.O.:
Long-term survival in a rodent model of disseminated brain tumors
by combined intrathecal delivery of herpes vectors and ganciclovir
treatment. Human Gene Therapy: in press, 1996
CHAPTERS
Chiocca E.A., Andersen J.K., Takamiya
Y., Martuza R.L., Breakefield X.O. Virus-mediated Genetic Treatment
of Rodent Gliomas. In: Gene Therapeutics. J.A. Wolff ed. (Birkhauser
Press Publishing Co., Boston), 1994, pp. 245-262.
Chiocca, E.A.: Genetic treatment
of brain tumors with the cyclophosphamide-activating CYP2B1 gene.
Clinical Neurosurgery vol.42, 1995, pp. 370-382.
Wei, M.X., Tamiya, T., Breakefield,
X.O., Chiocca, E.A.: Virus vector mediated transfer of drug-sensitivity
genes for experimental brain tumor therapy. In: Viral vectors:
gene therapy and neuroscience applications. (M.G. Kaplitt and
A.D. Loewy, eds.) Academic Press, San Diego, CA, 1995, pp. 239-259.
Breakefield, X.O., Kramm, C.M., Chiocca
E.A., Pechan, P.: Herpes simplex virus vectors for tumor therapy.
In: The Internet book of Gene Therapy: Cancer Gene Therapeutics.
(R. Sobol and K. Scanlon, eds.), 1995, pp 41-56.
Kramm, C., Breakefield, X.O., Chiocca
E.A.: Genetic strategies against brain tumors. In: The Internet
book of Gene Therapy: Cancer Gene Therapeutics. (R. Sobol and
K. Scanlon, eds.), 1995, pp 235-246.
Chiocca, E.A. and Harsh, G.R. IV:
Gene transfer technology and its application to brain tumor therapy.
In: The molecular basis for neurological surgery. (C. Raffel and
G.R. Harsh, eds.), 1996, in press.